Data / Ownership

Who is buying and selling the names we track.

How many shares are sold shortwe gathered it
8,027,660 shares
since 20 Sept 2026as of 2026-09-20

Neumora Therapeutics had 8,027,660 shares sold short at the last settlement.

How many shares are sold short
as of 2026-09-20
8,027,660 shareswe gathered itall
8,027,660
7,622,5487,723,8267,825,1047,926,3828,027,660
2026-07-152026-08-31

FINRA · monthly · history from the source back to 15 Jul 2026 · since 20 Sept 2026

Last observations

4 of 4
The last 4 observations
DaysharesChangeSource
2026-08-318,027,660+0.5%FINRA
2026-08-147,991,116+4.8%FINRA
2026-07-317,622,548−2.1%FINRA
2026-07-157,786,397FINRA

What happened

on this beat, newest first
  • 2026-09-21IMPINJ INC

    Baker Cary sold 8,892 shares at $185

    SEC EDGAR

  • 2026-09-21SYNAPTICS Inc

    Patel Rahul G. sold 2,276 shares at $93.83

    SEC EDGAR

  • 2026-09-19Hesai Group

    Fan Peng bought 50,000 shares

    SEC EDGAR

  • 2026-09-18Globalstar, Inc.

    Lynch James F sold 361,600 shares at $82.52

    SEC EDGAR

  • 2026-09-18Planet Labs PBC

    Marshall William Spencer sold 80,000 shares

    SEC EDGAR

  • 2026-09-18Globalstar, Inc.

    Monroe James III bought 361,600 shares at $82.52

    SEC EDGAR

  • 2026-09-18AMBARELLA INC

    Young John Alexander sold 1,896 shares at $67.28

    SEC EDGAR

  • 2026-09-18CoreWeave, Inc.

    Magnetar Financial LLC filed a Form 4 with no trade on it

    SEC EDGAR

Where it comes from

the sources and this month's misses
The sources behind this tracker
SourceCadenceRows this monthLast fetchMisses
FINRAshort-interest line per company/beatmonthly4482026-09-200

Take it with you

  • CSV, last 90 daysour numbers only on the page — the source's terms
  • Spreadsheet, last 90 daysour numbers only on the page — the source's terms
  • All of it, by APIa key, free to make
  • Embed this chartsoon · in Q4
  • Tell me when it movessoon · in Q4